Harry Lampiris

4.9k total citations · 2 hit papers
29 papers, 3.3k citations indexed

About

Harry Lampiris is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Harry Lampiris has authored 29 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 18 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Harry Lampiris's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Harry Lampiris is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Harry Lampiris collaborates with scholars based in United States, Switzerland and Slovakia. Harry Lampiris's co-authors include Jeffrey N. Martin, Steven G. Deeks, Elizabeth Sinclair, Peter W. Hunt, Barry M. Bredt, Joseph M. McCune, John L. Hunt, Dennis L. Stevens, Barry Hafkin and Daniel Herr and has published in prestigious journals such as JAMA, Nature Medicine and Clinical Infectious Diseases.

In The Last Decade

Harry Lampiris

28 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Cell Activation Is Associated with Lower CD4⁺T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

2003 676 citations Peter W. Hunt, Jeffrey N. Martin et al. The Journal of Infectious Diseases profile →
Relationship between T Cell Activation and CD4 ⁺ T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

2007 506 citations Peter W. Hunt, Jason M. Brenchley et al. The Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by Harry Lampiris

Since Specialization

Citations

This map shows the geographic impact of Harry Lampiris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Lampiris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Lampiris more than expected).

Fields of papers citing papers by Harry Lampiris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Lampiris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Lampiris. The network helps show where Harry Lampiris may publish in the future.

Co-authorship network of co-authors of Harry Lampiris

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Lampiris. A scholar is included among the top collaborators of Harry Lampiris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Lampiris. Harry Lampiris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between household exposure and cycle threshold in COVID-19 infected health care workers 2021 ·Journal of Occupational Medicine and Toxicology ·(unknown), (unknown), (unknown), (unknown), Chuanyi M. Lu, Harry Lampiris, Paul D. Blanc	1
2	Cycle Threshold to Test Positivity in COVID-19 for Return to Work Clearance in Health Care Workers 2020 ·Journal of Occupational and Environmental Medicine ·(unknown), (unknown), (unknown), Chuanyi M. Lu, Harry Lampiris, Paul D. Blanc	13
3	HIV latency in isolated patient CD4 ⁺ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing 2018 ·Science Translational Medicine ·Steven A. Yukl, Philipp Kaiser, Peggy Kim, Sushama Telwatte, Sunil K. Joshi, Mai Vu, Harry Lampiris, Joseph K. Wong	225
4	Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation 2016 ·Nature Medicine ·Peilin Li, Philipp Kaiser, Harry Lampiris, Peggy Kim, Steven A. Yukl, Diane V. Havlir, Warner C. Greene, Joseph K. Wong	88
5	Geriatric Syndromes in Older HIV-Infected Adults 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Meredith Greene, Kenneth E. Covinsky, Victor Valcour, Yinghui Miao, (unknown), Harry Lampiris, Irena Cenzer, Jeffrey N. Martin, Steven G. Deeks	174
6	Management of Human Immunodeficiency Virus Infection in Advanced Age 2013 ·JAMA ·Meredith Greene, Amy C. Justice, Harry Lampiris, Victor Valcour	124
7	Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor 2011 ·Expert Review of Anti-infective Therapy ·Harry Lampiris	21
8	A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response 2011 ·The Journal of Infectious Diseases ·Hiroyu Hatano, Timothy L. Hayes, Viktor Dahl, Elizabeth Sinclair, Tzong‐Hae Lee, Rebecca Hoh, Harry Lampiris, Peter W. Hunt, Sarah Palmer, Joseph M. McCune, Jeffrey N. Martin, Michael P. Busch, Barbara L. Shacklett, Steven G. Deeks	153
9	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy 2010 ·AIDS ·Steven A. Yukl, Amandeep K. Shergill, Kenneth R. McQuaid, Sara Gianella, Harry Lampiris, C. Bradley Hare, Mark Pandori, Elizabeth Sinclair, Huldrych F. Günthard, Marek Fischer, Joseph K. Wong, Diane V. Havlir	188
10	Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hiroyu Hatano, Harry Lampiris, Signe Fransen, Soumi Gupta, Wei Huang, Rebecca Hoh, Jeffrey N. Martin, Jacob Lalezari, David R. Bangsberg, Christos J. Petropoulos, Steven G. Deeks	62
11	Activity of Elvitegravir, a Once‐Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose‐Ranging Clinical Trial 2010 ·The Journal of Infectious Diseases ·Andrew Zolopa, Daniel S Berger, Harry Lampiris, Lijie Zhong, Steven L. Chuck, Jeffrey Enejosa, Brian P. Kearney, Andrew Cheng	103
12	Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapy 2009 ·Journal of NeuroVirology ·(unknown), Dieter J. Meyerhoff, Colin Studholme, John Kornak, Johannes Rothlind, Harry Lampiris, Jacqueline Neuhaus, (unknown), Linda L. Chao, Diana Truran, (unknown)	110
13	Relationship between T Cell Activation and CD4 ⁺ T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy breakdown → 2007 ·The Journal of Infectious Diseases ·Peter W. Hunt, Jason M. Brenchley, Elizabeth Sinclair, Joseph M. McCune, Michelle E. Roland, Kimberly Page, Priscilla Y. Hsue, Brinda Emu, Melissa Krone, Harry Lampiris, Daniel C. Douek, Jeffrey N. Martin, Steven G. Deeks	506
14	The independent effect of drug resistance on T cell activation in HIV infection 2006 ·AIDS ·Peter W. Hunt, Steven G. Deeks, David R. Bangsberg, Andrew R. Moss, Elizabeth Sinclair, Teri Liegler, Michael Bates, (unknown), Harry Lampiris, Rebecca Hoh, Jeffrey N. Martin	29
15	Prevalence of CXCR4 Tropism among Antiretroviral‐Treated HIV‐1–Infected Patients with Detectable Viremia 2006 ·The Journal of Infectious Diseases ·Peter W. Hunt, P. Richard Harrigan, Wei Huang, Michael Bates, David Williamson, Joseph M. McCune, Richard W. Price, Serena Spudich, Harry Lampiris, Rebecca Hoh, (unknown), Jeffrey N. Martin, Steven G. Deeks	109
16	T Cell Activation Is Associated with Lower CD4⁺T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy breakdown → 2003 ·The Journal of Infectious Diseases ·Peter W. Hunt, Jeffrey N. Martin, Elizabeth Sinclair, Barry M. Bredt, (unknown), Harry Lampiris, Steven G. Deeks	676
17	Simvastatin‐Nelfinavir Interaction Implicated in Rhabdomyolysis and Death 2002 ·Clinical Infectious Diseases ·C. Bradley Hare, Mai Vu, Carl Grünfeld, Harry Lampiris	64
18	Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study 2002 ·AIDS ·Robert T. Schooley, Peter Ruane, Robert A. Myers, Gildon Beall, Harry Lampiris, Daniel Berger, Shanshan Chen, Michael D. Miller, (unknown), Andrew Cheng	217
19	Linezolid versus Vancomycin for the Treatment of Methicillin‐Resistant Staphylococcus aureus Infections 2002 ·Clinical Infectious Diseases ·Dennis L. Stevens, Daniel Herr, Harry Lampiris, John L. Hunt, Donald H. Batts, Barry Hafkin, (unknown)	409
20	Streptococcus pneumoniae Transmission in Chronic-Care Facilities: Description of an Outbreak and Review of Management Strategies 1998 ·Infection Control and Hospital Epidemiology ·Donald C. Sheppard, (unknown), Harry Lampiris	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact